AdenineSalvage TherapyLimb SalvageAdenine NucleotidesOperative Blood SalvageAdenine Nucleotide Translocator 1NADPurinesAmputationMitochondrial ADP, ATP TranslocasesHypoxanthinesIschemiaHypoxanthineSite-Specific DNA-Methyltransferase (Adenine-Specific)Treatment OutcomeAdenosine MonophosphateAdenine Nucleotide Translocator 2Vascular PatencyLegTibial ArteriesAdenosine TriphosphateNADPAdenosine DiphosphateAdenosineRetrospective StudiesBlood Transfusion, AutologousFlavin-Adenine DinucleotideAdenosine Deaminase InhibitorsDeoxyadenosinesPurine NucleosidesInosineTime FactorsPurine NucleotidesNeoplasm Recurrence, LocalKineticsReoperationAtractylosideLower ExtremityAntineoplastic Combined Chemotherapy ProtocolsHypoxanthine PhosphoribosyltransferaseN-Glycosyl HydrolasesCombined Modality TherapyTreatment FailureNucleosidesAdenosine KinaseNicotinamidaseVeinsPentosyltransferasesFemoral ArteryRecurrenceTransplantation, AutologousVascular Surgical Procedures2-AminopurineSurgical FlapsArterial Occlusive DiseasesRiboseInosine MonophosphateFollow-Up StudiesPyrimidine NucleotidesIfosfamideMolecular Sequence DataThionucleosidesUracilLife TablesNucleotidesReconstructive Surgical ProceduresOrganophosphonatesAminohydrolasesRibosemonophosphatesAdenine Nucleotide Translocator 3Escherichia coliAzaserineDisease-Free SurvivalEtoposideMutationHodgkin DiseaseInguinal CanalBase SequenceBlood Vessel ProsthesisRemission InductionSurvival AnalysisAdenine PhosphoribosyltransferaseGangreneSurvival RateDNAVidarabineGuanosineNucleobase Transport ProteinsGerminomaBone NeoplasmsBinding SitesSubstrate SpecificityProstatectomyBongkrekic AcidOxidoreductasesAdenosine DeaminaseCytarabineLaryngectomyBlood Loss, SurgicalUridine